Correlating MIC with antimycobacterial efficacy against Mycobacterium abscessus by Jelmer Raaijmakers, Eline Kamps, Jakko Van Ingen

Get full text

Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey by Dirk Wagner, Jakko van Ingen, Roald van der Laan, Marko Obradovic

Get full text

Inhaled clofazimine adminsitration increases antimycobacterial effect compared to oral administration in a hollow-fibre system by Jelmer Raaijmakers, Rob E. Aarnoutse, Lindsey Te Brake, Ralf Stemkens, Heiman F.l. Wertheim, Wouter Hoefsloot, Jakko Van Ingen

Get full text

Bedaquiline does not enhance clofazimine treatment efficacy with an azithromycin-ethambutol backbone against Mycobacterium avium in a hollow fibre system by Jelmer Raaijmakers, Sandra Salillas, Rob E. Aarnoutse, Elin M. Svensson, Lindsey Te Brake, Ralf Stemkens, Heiman F.l. Wertheim, Wouter Hoefsloot, Jakko Van Ingen

Get full text

Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts by Michael R. Loebinger, Stefano Aliberti, Charles Haworth, Mateja Jankovic Makek, Christoph Lange, Natalie Lorent, Apostolos Papavasileiou, Eva Polverino, Gernot Rohde, Nicolas Veziris, Dirk Wagner, Jakko van Ingen

Get full text